Shanzheng Yang

1.0k total citations
22 papers, 681 citations indexed

About

Shanzheng Yang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Shanzheng Yang has authored 22 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 5 papers in Developmental Neuroscience. Recurrent topics in Shanzheng Yang's work include Pluripotent Stem Cells Research (7 papers), Nuclear Receptors and Signaling (7 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Shanzheng Yang is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), Nuclear Receptors and Signaling (7 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Shanzheng Yang collaborates with scholars based in Sweden, China and United Kingdom. Shanzheng Yang's co-authors include Ernest Arenas, Enrique M. Toledo, Carmen Saltó, Feng‐Yan Sun, Daniel Gyllborg, Lingmei Zhang, Feng‐Yan Sun, Per Uhlén, Jonathan H. Hecht and Samuel J. Pleasure and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shanzheng Yang

21 papers receiving 672 citations

Peers

Shanzheng Yang
Yaohong Wu United States
Lai Man Natalie Wu United States
Brian A. Pierchala United States
Nigel Kee Sweden
Malcolm Schinstine United States
Shanzheng Yang
Citations per year, relative to Shanzheng Yang Shanzheng Yang (= 1×) peers Perrine Gaub

Countries citing papers authored by Shanzheng Yang

Since Specialization
Citations

This map shows the geographic impact of Shanzheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanzheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanzheng Yang more than expected).

Fields of papers citing papers by Shanzheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanzheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanzheng Yang. The network helps show where Shanzheng Yang may publish in the future.

Co-authorship network of co-authors of Shanzheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shanzheng Yang. A scholar is included among the top collaborators of Shanzheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanzheng Yang. Shanzheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Wei, Qinqin Gao, Ziyan Wu, et al.. (2025). Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors. Cell stem cell. 32(9). 1457–1474.e7.
2.
Nishimura, Kaneyasu, Shanzheng Yang, Ka Wai Lee, et al.. (2022). Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation. Stem Cell Reports. 18(1). 337–353. 13 indexed citations
3.
Toledo, Enrique M., Shanzheng Yang, Daniel Gyllborg, et al.. (2020). Srebf1 Controls Midbrain Dopaminergic Neurogenesis. Cell Reports. 31(5). 107601–107601. 14 indexed citations
4.
Theofilopoulos, Spyridon, Shanzheng Yang, Eylan Yutuc, et al.. (2019). 24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo. Journal of Biological Chemistry. 294(11). 4169–4176. 29 indexed citations
5.
Yang, Shanzheng, Enrique M. Toledo, Changgeng Peng, et al.. (2018). A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration. Communications Biology. 1(1). 75–75. 13 indexed citations
6.
Gyllborg, Daniel, Maqsood Ahmed, Enrique M. Toledo, et al.. (2018). The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation. Stem Cell Reports. 11(3). 651–664. 19 indexed citations
7.
Okawa, Satoshi, Carmen Saltó, Srikanth Ravichandran, et al.. (2018). Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift. Nature Communications. 9(1). 2595–2595. 15 indexed citations
8.
Zhang, Dawei, Shanzheng Yang, Enrique M. Toledo, et al.. (2017). Niche-derived laminin-511 promotes midbrain dopaminergic neuron survival and differentiation through YAP. Science Signaling. 10(493). 49 indexed citations
9.
Li, Bingsi, Enrique M. Toledo, Pia Rivetti di Val Cervo, et al.. (2016). A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease. The EMBO Journal. 35(18). 1963–1978. 84 indexed citations
10.
Andersson, Emma, Carmen Saltó, Lukáš Čajánek, et al.. (2013). Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proceedings of the National Academy of Sciences. 110(7). E602–10. 104 indexed citations
11.
Lu, Huiyu, Yuejiao Huang, Hui Shi, et al.. (2013). Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma. Clinical & Translational Oncology. 15(10). 796–801. 12 indexed citations
12.
Yang, Shanzheng, Juan Antonio Sánchez‐Alcañiz, Nicolas Fritz, et al.. (2013). Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons. Development. 140(22). 4554–4564. 64 indexed citations
13.
Vuono, Romina, Clare L. Parish, Claire J. Foldi, et al.. (2012). Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens. Neurobiology of Disease. 49. 118–127. 27 indexed citations
14.
Liu, Hongmei, Shanzheng Yang, & Feng‐Yan Sun. (2010). 1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cells. Neuroscience Bulletin. 26(1). 1–7. 3 indexed citations
16.
Wang, Yongquan, et al.. (2009). VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochemistry International. 55(7). 629–636. 61 indexed citations
17.
Bian, Minjuan, Mei Yu, Shanzheng Yang, et al.. (2008). Expression of Cbl-interacting protein of 85 kDa in MPTP mouse model of Parkinson's disease and 1-methyl-4-phenyl-pyridinium ion-treated dopaminergic SH-SY5Y cells. Acta Biochimica et Biophysica Sinica. 40(6). 505–512. 18 indexed citations
18.
Yang, Shanzheng, et al.. (2008). Immunohistochemical Analysis of Nucleotide Excision Repair Factors XPA and XPB in Adult Rat Brain. The Anatomical Record. 291(7). 775–780. 4 indexed citations
19.
Yang, Shanzheng, et al.. (2003). Distribution of Flk‐1 and Flt‐1 receptors in neonatal and adult rat brains. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 274A(1). 851–856. 52 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026